Pharma Mar, S.A. (OTCMKTS:PHMMF - Get Free Report) was the target of a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 32,700 shares, an increase of 43.4% from the February 13th total of 22,800 shares. Approximately 0.2% of the company's stock are sold short. Based on an average trading volume of 100 shares, the short-interest ratio is currently 327.0 days.
Pharma Mar Price Performance
Shares of PHMMF stock remained flat at $102.08 on Wednesday. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.55 and a quick ratio of 2.01. Pharma Mar has a 12-month low of $26.85 and a 12-month high of $105.60. The company has a 50-day simple moving average of $93.08 and a 200-day simple moving average of $76.40.
About Pharma Mar
(
Get Free Report)
Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.
Read More
Before you consider Pharma Mar, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pharma Mar wasn't on the list.
While Pharma Mar currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
